CEREBROLYSIN 60 mg

$40.00

    Purity > 99% – View Lab Test

  • CompoundCerebrolysin
  • Amount60 mg per vial
  • FormLyophilized peptide complex
  • Purity≥99% (HPLC COA available)
  • ManufactureGMP-certified facility
  • Storage (dry)Cool, dry place
  • After reconstitution2–8 °C (short-term); ?20 °C for long-term

Out of stock

Description

Cerebrolysin 60 mg — Peptide-Based Neurotrophic Complex for CNS Research

Cerebrolysin is a peptide-based neurotrophic complex composed of
low–molecular weight peptides and amino acids derived from enzymatic protein hydrolysates.
In preclinical and clinical research, Cerebrolysin has been investigated for its potential
effects on neuronal survival, synaptic plasticity, cognitive performance, and
recovery after CNS injury
.

What It Is

  • Class: Peptide and amino-acid neurotrophic mixture
  • Composition: Low–molecular weight peptides & free amino acids
    (exact profile may vary by lot/specification)
  • Research focus: Neuroprotection, neuroplasticity, cognition, and
    recovery in central-nervous-system models.

Proposed Mechanisms (Preclinical)

Neurotrophic & Synaptic Effects

  • Investigated for neuronal survival–supportive activity in
    excitotoxic, ischemic, and neurodegenerative models.
  • Explored for modulation of neurotrophic-factor signaling
    (e.g., BDNF-related pathways) and synaptic plasticity markers.
  • Experimental data examine impacts on dendritic complexity, synapse
    density, and network connectivity
    in CNS tissues.

Metabolic & Anti-Inflammatory Pathways

  • Used in models assessing oxidative stress, mitochondrial function,
    and apoptotic signaling
    in neurons.
  • Preclinical work includes effects on neuroinflammatory markers
    and glial-cell responses after injury.
  • Interest in combined neuroprotective and neurorestorative
    profiles in chronic CNS conditions.

Selected Research Highlights

  • Stroke & Ischemia Models: Cerebrolysin has been studied in
    ischemic brain injury for impacts on infarct size, functional recovery,
    and neurologic scores in animal and clinical research.
  • Cognitive & Memory Research: Experimental work examines
    learning, memory, and executive-function endpoints in aging and
    disease-related models.
  • Neurodegenerative Contexts: Investigated in preclinical and selected
    clinical settings for effects on cognitive decline and neurodegenerative
    markers
    .

Chemical & Handling Information

  • Type: Peptide-based neurotrophic complex
  • Form: Lyophilized peptide mixture for laboratory reconstitution
  • Appearance: White to off-white lyophilized powder

Specifications

  • Compound: Cerebrolysin
  • Amount: 60 mg per vial
  • Form: Lyophilized peptide complex
  • Purity: ?99% (HPLC); COA per lot available
  • Packaging: Sealed vials suitable for standard laboratory handling

Storage & Stability

  • Store lyophilized vials in a cool, dry place, protected from light.
  • Refrigeration or freezing of the lyophilized material is recommended for extended stability,
    according to laboratory SOPs.
  • After reconstitution, store at 2–8 °C for short-term use.
  • For long-term storage, aliquot and freeze at ?20 °C or below;
    avoid repeated freeze–thaw cycles.

Reviews

There are no reviews yet.

Be the first to review “CEREBROLYSIN 60 mg”

Your email address will not be published. Required fields are marked *